Detalhe da pesquisa
1.
Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
J Microbiol Methods
; 90(2): 83-5, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22565213
2.
Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients.
J Acquir Immune Defic Syndr
; 68(1): e10-2, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25321178